Oncoinvent ASA
OSE:ONCIN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Oncoinvent ASA
OSE:ONCIN
|
NO |
|
N
|
Nissan Chemical Corp
F:NSC
|
JP |
|
Verisk Analytics Inc
F:VA7A
|
US |
|
U
|
Unilever Indonesia Tbk PT
XMUN:UTG
|
ID |
|
B
|
Befimmo SA
F:VJ6
|
BE |
|
D
|
Deutsche Effecten und Wechsel Beteiligungsgesellschaft AG
SWB:EFF
|
DE |
|
F
|
flatexDEGIRO AG
XBER:FTK
|
DE |
|
S
|
Schoeller Bleckmann Oilfield Equipment AG
XBER:SLL
|
AT |
|
H
|
Hydrocarbon Dynamics Ltd
OTC:PYMOD
|
AU |
|
Host Hotels & Resorts Inc
NASDAQ:HST
|
US |
|
W
|
Wynn Resorts Ltd
SWB:WYR
|
US |
|
R
|
Rush Enterprises Inc
F:RUNA
|
US |
|
L
|
Linde PLC
XHAM:LIN
|
UK |
|
M
|
MasTec Inc
SWB:MY8
|
US |
|
Catena AB
F:T9R
|
SE |
|
Crane Co
F:T12
|
US |
|
C
|
Cabot Corp
F:CBT
|
US |
|
L
|
LVMH Moet Hennessy Louis Vuitton SE
DUS:MOH
|
FR |
|
B
|
Buckle Inc
SWB:BK2
|
US |
|
Fuji Electric Co Ltd
OTC:FELTF
|
JP |
|
E
|
electroCore, Inc.
F:43E
|
US |
|
Sparc AI Inc
OTC:SPAIF
|
AU |
|
I
|
Industrials REIT Ltd
JSE:MLI
|
UK |
Bankruptcy Probability
Oncoinvent ASA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Oncoinvent ASA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NO |
O
|
Oncoinvent ASA
OSE:ONCIN
|
225.8m NOK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
611.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
318B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
241.5B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
354.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Oncoinvent ASA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Oncoinvent ASA has no debt.
You can find a full breakdown on its Balance Sheet.
